News for men with metastatic prostate cancer, advances in sarcoma diagnosis and treatment, and summer travel tips for people in active treatment.
View current issue now »
- June 2016
Invitation to a livestream of Vice President Biden’s first national Cancer Moonshot initiative summit conversation, MSK patients express LGBT pride, and news of a key AML discovery.
- May 2016
Vice President Biden leads a brainstorming session on the national Cancer Moonshot initiative at MSK, the FDA approves two immunotherapy drug combinations, and Humans of New York highlights our pediatrics department.
- April 2016
The Parker Institute for Cancer Immunotherapy launches, watchful waiting with lymphoma, and highlights from the American Association for Cancer Research meeting.
- March 2016
MSK’s Teen and Young Adult Program begins, how to spare normal tissue when manipulating the immune system to fight cancer, and news of a surprising novel treatment for venous malformation.
- February 2016
Celebrating nursing excellence at MSK, tips on searching for reliable cancer information online, and what to expect at the new Josie Robertson Surgery Center.
- January 2016
President Obama’s “moonshot” to cure cancer, ovarian cancer screening for average-risk women, and convincing reasons to abstain from alcohol if you have liver cancer.
- December 2015
Understanding Jimmy Carter’s surprise cancer turnaround, how women can benefit from recent advances in breast screening tests, and insights on a Netflix-inspired approach to studying biology and medicine.
- November 2015
Our Josie Robertson Surgery Center is poised to transform outpatient cancer surgery, ideas on what doctors can do to avoid misdiagnoses, and what men should know about complication risks with prostate cancer surgery.
- October 2015
Women at average risk for breast cancer should start screening mammograms at age 40, Agent Orange exposure is linked to a precursor of multiple myeloma, and MSK experts talk about whether red meat raises cancer risk.
- September 2015
New drugs for advanced renal cell carcinoma, evidence that active surveillance may be the best approach for early-stage thyroid cancer, and a clinic for lymphoma survivors opens at MSK.